Company Overview of Imarx Therapeutics, Inc.
As of May 14, 2010, Imarx Therapeutics, Inc. was acquired by Sycamore Films, Inc., in a reverse merger transaction. Previously, the company focused on the research, development, and commercialization of therapies for stroke and other vascular disorders using its microbubble technology. Its lead program, SonoLysis, involves the administration of its MRX-801 microspheres and ultrasound to break up blood clots and restore blood flow to oxygen deprived tissues. The company was founded in 1999 and is based in Redmond, Washington.
12277 134th NE
Redmond, WA 98052
Founded in 1999
Key Executives for Imarx Therapeutics, Inc.
Imarx Therapeutics, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|Sitari Pharmaceuticals, Inc.||United States|
|P2D, Inc.||United States|
|Vascular Genetics Inc.||United States|
|US Pharma Lab, Incorporated||United States|
|Longevica Pharmaceuticals, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Imarx Therapeutics, Inc., please visit www.imarx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.